Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Screening Strategies for Scleroderma PAH (Pulmonary Arterial Hypertension)

NCT01959815 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01959815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01959815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Screening Strategies for Scleroderma PAH (Pulmonary Arterial Hypertension)
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Completed
Start date
September 26, 2013
Completion date
November 6, 2019
Enrollment
156 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension, scleroderma